Theresa Podrebarac, M.D., M.Sc.

Chief Medical Officer

Dr. Theresa Podrebarac is a 17-year industry veteran with extensive pharmaceutical drug development expertise from both large pharma and smaller biotech companies. She joins Phoenix Tissue Repair from enGene Inc. where she served as both the CSO and CMO to advance the company’s portfolio of novel nanoparticle delivered local gene therapies. Prior to joining enGene, Dr. Podrebarac served as Vice President, immunology clinical development at AbbVie, where she led the immunology therapeutic area to develop the future vision for the company’s portfolio and introduced integrated biomarker techniques and quantitative decision tools to early clinical development. Previously, she was Vice President of early clinical development and immunology at Biogen. Dr. Podrebarac is a board certified rheumatologist who earned her medical degree from the University of Western Ontario, her masters of immunology at the University of Ottawa while completing post-doctoral training in T-cell immunology at Harvard University and provided patient care at Brigham and Women’s Hospital in Boston.